Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Elizabeth Rose Struhs, 8, died at her family's home after six days without her prescribed insulin shots for type-1 diabetes.

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...